Skip to content
CRVL

CorVel Corporation

CorVel Corporation Q3 FY2022 earnings call

February 1, 2022 · fiscal period ended 2021-12

EPS · actual vs est

$0.25 /

Revenue · actual vs est

$164.5M /
Ask about this call

Summary

Generated 2022-02-01

Management highlights

  • New sales remained robust in the quarter, with new bookings in 2021 reaching a record high. The sales staff navigated the new normal of virtual and in-person meetings well. - The December quarter was affected by the New Year's holiday falling in December, but the March quarter will benefit from more working days. - The organization adjusted well during the pandemic, with strong recruiting and retention due to an entrepreneurial culture, work-from-home flexibility, and robust production systems. - Responding to wage inflation by balancing salary adjustments with investments in customer service, and leveraging historical investments in web-based production systems to offset inflation impacts. - Flexed with pandemic changes, expanding telehealth activities and investing in care management systems. - Private equity has left competitors highly leveraged, and higher interest rates may increase industry churn. - Innovative care delivery (virtual care) reduces costs, and CorVel is well-positioned with proprietary systems. - Symbeo offers on-demand revenue cycle management, using technology to improve service. - Payment integrity programs are crucial, with CERiS core to prepayment review, relying on technology for differentiated solutions. - Project development focuses on expanding prepay payment integrity solutions, enhancing interfaces, optimizing virtual care, AI/ML, and system automation.
View in transcript ↓

Segment performance

For the December 2021 quarter, revenues were $164 million. The patient management segment (including third-party administration, TPA services, and traditional case management) had revenue of $108 million, an annual increase of 12%. Gross profit in this segment decreased 2% from the prior year quarter due to calendar effects. The Network Solutions segment, which sells in the wholesale market, had revenue of $57 million, up 26% from the prior year quarter. Gross profit in the wholesale business was up 30% from the prior year quarter, with gross margins increasing due to a higher percentage of health market business within Network Solutions. Revenue contribution: Patient management likely contributed a significant portion, with Network Solutions also making a notable contribution.

View in transcript ↓

Guidance

  • The March quarter will benefit from an increased number of working days without the typical New Year's holiday. - Investments in technology are expected to continue neutralizing increased costs due to inflation. - The strong new sales in 2021 provide positive tailwinds into future quarters.
View in transcript ↓

Risks

  • Higher interest rates are likely to impact highly leveraged market competitors. - Inflation and corresponding higher interest rates may increase churn in the competitive environment as the debt of highly leveraged companies matures. - The pandemic changed the mix of workplace injuries and made healthcare facilities challenging to manage.
View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$0.25$0.21
Revenue$164.5M$141.5M

Transcript

February 1, 2022

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.